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 CURRENTOPINION Fighting obesity by targeting factors regulating
beige adipocytes
Allison E. McQueena, Suneil K. Koliwadb, and Jen-Chywan Wanga
Purpose of review
The current review provides an update on secreted factors and mechanisms that promote a thermogenic
program in beige adipocytes, and their potential roles as therapeutic targets to fight obesity.
Recent findings
We outline recent studies revealing unrecognized mechanisms controlling beige adipocyte physiology, and
summarize in particular those that underlie beige thermogenesis independently of classical uncoupling. We
also update strategies aimed at fostering beige adipogenesis and white-to beige adipocyte conversion.
Finally, we summarize newly identified endogenous secreted factors that promote the thermogenic
activation of beige adipocytes and discuss their therapeutic potential.
Summary
The identification of novel endogenous factors that promote beiging and regulate beige adipocyte-specific
physiological pathways opens up new avenues for therapeutic engineering targeting obesity and related
metabolic disorders.
Keywords
beige adipocyte, brown adipose tissue, metabolic disease, obesity, secreted factors, thermogenesis,
uncoupling protein-1
INTRODUCTION
Obesity and consequent metabolic disorders, such
as type 2 diabetes, are an increasingly serious global
health problem and reflect a need for more compre-
hensive and effective strategies for prevention, treat-
ment, and even reversal. Given that obesity results
when bodily energy intake exceeds expenditure, one
potential solution would be to increase energy
expenditure. Indeed, tunable strategies to mini-
mally enhance energy expenditure over prolonged
periods of time could both prevent and potentially
reverse obesity without substantial risk for
unwanted off-target effects. This review discusses
several avenues of progress towards this goal.
Adipose tissue maintains the critical balance
between lipid storage and utilization for energy.
Two basic types of adipose tissue have been identi-
fied – white adipose tissue (WAT), which is respon-
sible for storage of excess triglycerides, and brown
adipose tissue (BAT), which is specialized to dissi-
pate energy by producing heat. One key difference
between WAT and BAT is that the latter expresses
uncoupling protein-1 (UCP1), a transmembrane
protein in mitochondria that is responsible for
heat generation.
Additionally, precursor cells existing mainly
within subcutaneousWAT depots can be stimulated
to differentiate into thermogenic ‘beige’ or ‘brite’
adipocytes [1–3]. Conversion to a thermogenic phe-
notype or ‘beiging’ in these cells can be triggered
by cold exposure and by b3-adrenergic receptor
or peroxisome proliferator-activated receptor g
(PPARg) agonists, promoting UCP1 expression and
b-oxidation, and uncoupled respiration [1,2]. Acti-
vated beige adipocytes burn free fatty acids to gen-
erate heat similar to a bona fide brown adipocyte
within the BAT [2,4]. Although it is estimated that
beige adipocytes only contribute about one-fifth of
the thermogenic capacity generated by BAT, at least
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in rodents, their physiological contribution to
energy homeostasis and systemic metabolism is still
important [4]. Stimulating WAT beiging increases
energy expenditure, produces antiobesity effects,
and improves glucose tolerance and insulin sensi-
tivity in several mouse models [2–4]. Moreover, the
recruitable nature of beige cells operant within the
WAT makes them attractive therapeutic targets,
prompting interest in the factors and pathways
regulating their number and function.
CLINICAL RELEVANCE OF BEIGE ADIPOSE
TISSUE
With the goal of identifying factors capable of
inducing WAT beiging to treat metabolic disorders,
the important question is whether humans are capa-
ble of such a phenomenon. Several studies have now
identified that classical ‘brown’ adipocytes and
recruitable beige adipocytes differentiate from dis-
tinct developmental lineages and exhibit distinct
gene expression signatures [5,6]. Humans are born
with BAT located in the interscapular region that
contains adipocytes expressing the classical brown
profile [7,8]. This BAT involutes over the next sev-
eral months, and traditional thinking held that
humans, unlike rodents, are devoid of true BAT after
the newborn period [9]. However, more recent met-
abolic tracer studies using PET imaging demonstrate
that adult human participants have considerably
sized depots of metabolically active adipose tissue
that avidly take up glucose [10,11]. Indeed, it is now
known that thermogenic fat stores increase within
the body over the first decade of life, and in response
to puberty [12,13].
Adult humanBAT, however, exhibits differences
when compared with newborn human BAT or
interscapular BAT in adult rodents. First, the ther-
mogenic capacity of adult BAT is highly inducible by
cold and adrenergic stimulation [14,15]. Indeed,
several studies on human subjects have shown that
daily, mild (e.g. 19 8C), short-term (2h) cold expo-
sure increases energy expenditure, reduces fat mass,
and improves insulin sensitivity in association with
activation of intra-thoracic BAT [15,16]. Consistent
with this, BAT mass is higher in adult humans who
live in cold climates, and in the winter versus sum-
mer [17]. Moreover, the amount and activity of
adult BAT is decreased in obese individuals [2,18].
Taken together, this information highlights the
energetic andmetabolic importance of adult human
BAT, and the potential clinical benefit of developing
strategies to promote BAT recruitment and thermo-
genic activation.
The functional differences between the BAT of
adult humans and rodents have been probed at the
cellular level. This work revealed that adipocytes
from supraclavicular fat, which was thought to rep-
resent classical BAT, in fact express a gene profile
reminiscent of beige adipocytes [1–3]. Genome-
wide analysis shows that UCP1þ adipocytes derived
from human BAT samples display a transcriptional
profilemore similar tomurine beige adipocytes than
classical interscapular brown adipocytes. Thus,
human adult ‘BAT’ depots are in fact mainly consti-
tuted of beige-like adipocytes that are competent for
ligand-stimulated activation [5]. This conclusion
has led to a proliferation of research focused on
finding secreted factors that control the beiging
process.
SECRETED FACTORS MODULATE BEIGE
ADIPOCYTE ACTIVATION
Space limitations preclude us from discussing all the
signaling molecules regulating beige adipogenesis
and function here. Several of these have already
been reviewed [3,19]. Instead, we will focus specifi-
cally on endogenously synthesized and physiologi-
cally important secreted factors that may be
effectively targeted from a therapeutic standpoint.
Secreted factors and their corresponding recep-
tors have become attractive therapeutic targets
against metabolic diseases because by manipulating
endogenous endocrine, paracrine, and/or autocrine
pathways that are already in place, we may achieve
clinically relevant outcomes without all the unde-
sirable off-target effects associated with traditional
drug discovery. For example, catecholamines acting
via the b3-adrenergic receptor directly stimulate the
classical pathway that activates beige adipocytes.
However, developing adrenergic ligands for obesity
and metabolic disease applications could produce
KEY POINTS
 Human beings have a substantial reservoir of beige
adipocytes that can be recruited to enhance energy
expenditure; targeting these cells represents a clear
opportunity to improve metabolic health.
 The identification of unrecognized endogenous factors
that promote beiging offer new potential avenues for
therapeutic engineering targeting obesity and related
metabolic disorders.
 Recent studies have identified UCP1-independent
pathways that promote beige adipogenesis,
thermogenesis, and/or conversion between beige and
white adipocyte phenotypes, highlighting the
complexity of adipose tissue energetics and the number
of different strategies that may be leveraged for clinical
purposes.
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unwanted autonomic, bone, and cardiovascular
effects over time. Similarly, bone morphogenetic
proteins 4, 7, and 8b (BMP4, BMP7, BMP8b), atrial
and brain-type natriuretic peptides, FGF21, VEGF-A,
and prostaglandins, have all been shown to promote
beiging in vivo [20–25]. However, these factors may
also exert potentially unwanted pleiotropic effects
when translated into drugs. Indeed, the develop-
ment of FGF21 mimetics was halted after phase I
trials because of adverse effects [26]. By contrast,
several more recently identified endogenous factors
show promise as beiging agents and examination
of their therapeutic potential is thus continuing
aggressively. Belowwe summarize intriguing endog-
enous secreted factors identified in the last 2 years
and discuss their therapeutic potential.
Slit2
Slit2 is a factor secreted by beige adipocytes under
transcriptional control of PRDM16, a master-regula-
tor of beige/brown adipocyte differentiation [27
&
].
Slit2 is posttranslationally cleaved, and functional
studies reveal that the C-terminal fragment of Slit2
promotes thermogenesis cultured white adipocytes
and in mice by activating the PKA-p38 MAP kinase
pathway (Fig. 1) [27
&
].
Interestingly, adenoviral overexpression of C-
terminal Slit2 in the livers of diet-induced obese
mice increased whole-body energy expenditure
and improved glucose tolerance, suggesting that
systemically administering purified Slit2 C-terminal
protein in isolation could produce beneficial effects
[27
&
]. Previous studies showed that Slit proteins bind
to the Robo family of receptors through their N-
terminal region to activate the small GTPase Cdc42
[28], whereas the receptor for the C-terminus of
Slit2 is unknown. Notably, although full-length
Slit2 also promotes beiging, the truncated C-termi-
nal Slit2 proteinmight provide amore specific effect
therapeutically.
Angiopoietin-like 4
Angiopoietin-like 4 (ANGPTL4) is a secreted protein
highly expressed in liver and adipose tissues, whose
FIGURE 1. Newly discovered pathways in the physiology of beige adipocytes. Shown are several recently identified
endogenous secreted factors that regulate beige thermogenesis. Note that these factors, acting via recognized and as yet
unknown receptors, converge primarily onto the PKA-p38MAPK and ERK-signaling pathways. Interestingly, two of these
factors, Slit2 and ANGPTL4, are cleaved, with the pro-thermogenic domain of each protein being confined to the C-terminal
fragment. These factors have been shown to augment classical (UCP1-dependent) uncoupling to produce metabolically
desirable effects. Shown also are UCP1-independent pathways recently found to operate in beige adipocytes as well. These
include thermogenesis resulting from futile calcium cycling into and out of intracellular stores, Parkin-dependent mitophagy
during beige-to-white adipocyte interconversion, and futile creatine cycling within the mitochondrial outer matrix. These factors
and pathways greatly expand the number of potential therapeutic targets that may be exploited to reverse obesity and
associated metabolic diseases. UCP-1, uncoupling protein-1.
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expression is induced by environmental cues
including fasting, hypoxia, and glucocorticoids.
As with Slit2, ANGPTL4 has distinct structural
and functional domains corresponding with its N-
terminal and C-terminal halves. Initial studies of
ANGPTL4 focused on its ability to inhibit lipopro-
tein lipase, an activity that is specifically exerted by
its N-terminal coiled-coil domain (CCD) [29]. How-
ever, ANGPTL4 also promotes intracellular triacyl-
glycerol hydrolysis (lipolysis) in adipocytes by
stimulating cAMP production (Fig. 1) [30]. This
action is independent of the CCD, and is now
known to be exerted specifically by the C-terminal
fibrinogen-like domain (FLD) of ANGPTL4 [31
&
].
Increasing circulating ANGPTL4 FLD levels in isola-
tion induced in-vivo adipose tissue lipolysis, pro-
tected mice against high-fat diet-induced obesity,
ectopic steatosis, and glucose intolerance [31
&
]. In
addition, ANGPTL4 FLD increased oxygen con-
sumption and the expression of thermogenic genes,
such as UCP1 and PGC-1a, in inguinal WAT, an
indication of beiging [31
&
]. These effects resulted
in increased whole-body energy expenditure [31
&
].
The receptor mediating ANGPTL4 FLD effects on
adipocytes is unknown, however, previous studies
showed that ANGPTL4 FLD associates with integ-
rins, including b1, b3, and b5, to stimulate cell
migration and apoptosis in cancer cells and kerati-
nocytes [29]. The role of integrin-dependent signal-
ing in ANGPTL4 FLD-induced beiging, however, is
unclear. Although full-length ANGPTL4 also likely
induces beiging, the C-terminal ANGPTL4 FLD
could be more beneficial therapeutically, as admin-
istering it would avoid the inhibition of lipoprotein
lipase and consequent hypertriglyceridemia stimu-
lated by the N-terminal CCD [10].
Adrenomedullin 2
Adrenomedullin 2 (ADM2) is a secreted peptide
from the calcitonin gene-related peptide family.
Plasma ADM2 levels are inversely correlated with
obesity in humans [32
&
]. Adipose-specific ADM2
transgenic mice are resistant to diet-induced obe-
sity, have increased whole body energy expenditure,
and increased beiging in subcutaneous WAT [32
&
].
AMD2 exerts two mechanisms to promote beiging.
First, treating rat primary subcutaneous adipocytes
and human adipocytes with ADM2 increased
expression of genes encoding UCP1 and other ther-
mogenic proteins, and promoted uncoupled mito-
chondrial respiration [32
&
]. The receptor for ADM2
is composed of a calcitonin receptor-like receptor
(CRLR) and one of the three receptor activity-modi-
fying proteins (RAMPs) (Fig. 1) [33]. ADM2-stimu-
lated beiging was shown to be mediated by RAMP1
and its downstream effectors, PKA and p38 MAPK
[32
&
]. In addition, ADM2 promotes the polarization
of resident subcutaneous WAT macrophages to an
M2-like state, which has recently been implicated in
regulating catecholamine levels and action in the
WAT [32
&
,34]. ADM2-activated WAT macrophages
are suggested to be important to the mechanism by
which ADM2 promotes beiging, perhaps by produc-
ing paracrine factors that functionally modulate
neighboring adipocytes [32
&
,35]. However, ADM2
also impacts the cardiovascular system and can
produce hypotension in animal models [33]. There-
fore, targeting ADM2-dependent signaling to curb
obesity will require a strategy to do so in a WAT-
specific manner.
Kynurenic acid
Kynurenine is a neurotoxic metabolite of trypto-
phan [36]. Exercise increases conversion of kynur-
enine to kynurenic acid in skeletalmuscle and in the
circulation [37
&
]. Unlike kynurenine, kynurenic acid
cannot cross the blood–brain barrier. Daily kynur-
enic acid injection in C57BL/6 mice increased
energy expenditure [37
&
]. Global gene expression
analysis in this context shows that kynurenic acid
induces a beige adipocyte signature and increases
expression of lipid metabolism and anti-inflamma-
tory genes [37
&
]. Kynurenic acid acts through its
receptor, G protein-coupled receptor 35 (Gpr35),
to activate ERK and CREB, and to subsequently
increase PGC-1a expression and cellular respiration
(Fig. 1) [37
&
]. Kynurenic acid-Gpr35 signaling also
increases intracellular levels of Rgs14, leading to
enhanced b-adrenergic receptor signaling [37
&
].
Notably, Gpr35-deficient mice are resistant to exer-
cise-induced beiging of subcutaneous WAT [37
&
].
Interestingly, 2 weeks of daily kynurenic acid treat-
ment in mice with diet-induced obesity reduced
body weight and inguinal WATmass, and improved
glucose tolerance and plasma triglyceride levels
[37
&
]. Overall, tissue-selective Gpr35 agonists could
be an intriguing antiobesity approach.
TGR5
TGR5 is a G protein-coupled receptor for bile acids
[38], and cold-inducedWAT beiging was attenuated
in TGR5-deficient mice [39
&
]. Under thermoneutral
conditions, at which there is no ambient tempera-
ture-associated thermogenic stress, activating TGR5
with systemic TGR5-selective bile acid mimetics
promotes subcutaneous WAT beiging in wild-type,
but not TGR5-null mice [39
&
]. Not surprisingly,
TGR5-selective bile acid mimetics also induce
beiging and reduce body weight gain in mice with
Nutrition and physiological function
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diet-induced obesity [39
&
]. Adding the TGR5 agonist
INT-777 to differentiation media bathing adipo-
genic precursor cells from theWAT stromal vascular
fraction of wild-type mice augmented the expres-
sion of thermogenic genes [39
&
]. INT-777 was shown
to induce mitochondrial fission and respiration in
an ERK/DRP1-dependent manner (Fig. 1) [39
&
].
Although TGR5 is a potentially desirable therapeutic
target, TGR5 agonists also produce several
unwanted effects as well, including gallbladder
expansion, impaired immune function, and alter-
ations in heart rate [40,41]. These off-target effects
could limit the development of TGR5-based thera-
pies. As such, any potential antiobesity approach
focused on TGR5 may have to be engineered to be
WAT specific.
Immune signals
Group 2 innate lymphoid cells (ILC2s) and M2
macrophages remain an active focus in metabolic
research [32
&
,34], though the specific role of macro-
phages in catecholamine metabolism has been
recently questioned [42]. A recent study found that
FGF21 activates type 2 immunologic responses in
the WAT by inducing adipocytes to express the
chemokine CCL11 [43]. Moreover, the activation
of histamine receptor has been shown to induce
PKA signaling, leading to UCP1 expression and sub-
cutaneous WAT beiging [44]. In targeting immune
signals to stimulate beiging, however, effective strat-
egies will require that this targeting is specific to the
WAT and/or BAT, and to metabolic and tempera-
ture-sensitive triggers, to lessen the possibility of
either autoimmunity or immunosuppression in a
broader sense.
NEW INSIGHTS ON BEIGE ADIPOCYTE
PHYSIOLOGY
Most studies of secreted factor effects on beige
adipocyte differentiation and physiology use
rodent models. Notably, as we discussed above,
there are differences between rodent and human
BAT and they could respond to secreted factors
differently. Recent studies show that human BAT
is activated by acute glucocorticoid treatment,
whereas in rodent BAT, glucocorticoids signifi-
cantly suppress thermogenesis [45]. Moreover,
human BAT does not respond to certain b3-adren-
ergic receptor agonists as well as rodent BAT [46].
Thus, it is important to establish human stem cell
models to study the effects of secreted factors on
beige adipocyte differentiation. Recently, one
group had success differentiating human pluripo-
tent stem cells (hPSCs) throughmesenchymal stem
cells to thermogenically active adipocytes most
closely, physiologically resembling beige adipo-
cytes [47]. The current progress of developing
human stem cell-based models of thermogenic adi-
pocytes has been reviewed in a recent article [48].
Most of the secreted factors described thus far
promote beiging through activation of the cAMP-
PKA pathway (Fig. 1). Recent studies, however, have
revealed additional, previously unrecognized phys-
iological pathways that induce WAT beiging with-
out altering the function of bona fide brown
adipocytes. These pathways provide new directions
in screening for secreted factors that promote beige
differentiation and activation.
One such pathway underlies a UCP1-indepen-
dent thermogenic mechanism newly identified in
beige adipocytes residing in WAT, which express
UCP1 at much lower levels than do brown adipo-
cytes residing BAT. This discovery stemmed from
the initial observation that mice lacking UCP1 con-
tain beige adipocytes capable of thermogenesis
[49
&&
]. In these mice, enhanced ATP-dependent cal-
cium cycling in beige adipocytes by the sarco/endo-
plasmic reticulum Ca2þ-ATPase 2b (SERCA2b) and
the type 2 ryanodine receptor (RyR2) promotes
thermogenesis, whereas this pathway is expendable
in BAT thermogenesis [49
&&
]. The mechanism for
this cell type specificity is unclear, but may hinge
on the higher cellular availability of ATP in beige, as
opposed to brown adipocytes [49
&&
]. PKA enhances
this thermogenic mechanism by phosphorylating
RyR2, potentiating calcium release from the sarco/
endoplasmic reticulum.
Creatine metabolism has also been shown to
play a role in maintaining thermogenesis indepen-
dently of UCP1. The expression of genes regulating
creatine metabolism was elevated in UCP1-deficient
mice, and reducing creatine levels in these mice
decreased core body temperature and oxygen con-
sumption byWAT beige cells [50]. Reducing creatine
levels also decreased cold-inducible and catechol-
amine-inducible energy expenditure in both WAT
and BAT [50].
Beige adipocytes spontaneously revert to a clas-
sical white-like phenotype, including development
of hallmark unilocular lipid droplets, without the
constant presence of stimuli to maintain their ther-
mogenic phenotype [18]. This beige-to-white con-
version may be because of autophagy-mediated
mitochondrial degradation [51
&
]. Parkin, an E3
ubiquitin ligase that initiates mitophagy, has
been identified as a crucial mediator of adipocyte
beige-to-white transition [51
&
]. Beige adipocytes in
mice lacking Parkin do not responsively degrade
their mitochondria upon cessation of external beig-
ing stimuli. Notably, Parkin is not relevant to
Fighting obesity using beige adipocytes McQueen et al.
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mitochondrial maintenance in bona fide brown
adipocytes or BAT [51
&
]. Interestingly, UCP1 is not
required to recruit Parkin to mitochondria, or for
mitophagy during beige-white adipocyte conver-
sion, indicating that this control of beige adipocyte
maintenance is UCP1-independent [51
&
].
Warming also induces the ‘whitening’ of beige
adipocytes. Epigenomic studies reveal that warming
beige adipocytes in culture shifts their chromatin
state to one resembling lipid-storing white adipo-
cytes [52
&
]. However, these whitened beige adipo-
cytes retain an array of ‘poised’ transcriptional
enhancers that prime thermogenic genes for a rapid
transcriptional conversion back to a beige pheno-
type upon the next cold exposure. The glucocorti-
coid receptor and the zinc finger protein Zfp423
have been identified as key transcriptional regula-
tors of the whitening of beige adipocytes. Interest-
ingly, bona fide interscapular brown adipocytes do
not significantly change chromatin state during
warming despite morphological indicators of whit-
ening [52
&
].
The identification of functionally important
UCP1-independent thermogenic mechanisms
employed by beige adipocytes expands the number
of approaches targeting adipocytes to fight obesity
(Fig. 1). However, whereas enhancing Ca2þ-cycling
to promote thermogenesis could have therapeutic
potential, forcing Ca2þ-cycling in cells beyond adi-
pocytes could have adverse effects on cardiac and
skeletal muscle function. Thus, stimulating these
UCP1-independent pathways in an adipose-specific
manner is critical. Minimizing beige-to-white adi-
pocyte conversion could be another approach to
enhance beige adipocyte activity.
CONCLUSION
We have summarized some newly identified endog-
enous secreted factors that promote beige adipocyte
activation. The identification of Slit2 and ANGPTL4,
in this regard, are especially intriguing, as targeting
specific functional domains of each of these factors
may hold therapeutic promise without the adverse
effects that might be attendant with the entire full-
length proteins. The identification of UCP1-inde-
pendent mechanisms for adipose tissue thermogen-
esis and pathways governing beige-to-white
adipocyte conversion provide alternative therapeu-
tic avenues as well. Regardless, a key remaining task
is confining the action of any beiging-oriented ther-
apeutics specifically to the adipose tissue, and avoid-
ing effects on tissues elsewhere in the body.
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